Galya Blachman

Galya Blachman

Algemeen Adviseur bij 501 ACQU
49 jaar
Consumer Services
Health Technology
Finance

Profiel

Galya D.
Blachman
is currently Chief Legal Officer & Head-Business Development at Enliven Therapeutics, Inc. since 2023.
Legal Advisor at 5AM Venture Management LLC since 2022.
Secretary & General Counsel at 5:01 Acquisition Corp.
since 2020.
General Counsel at Biotech Connection-Bay Area, Inc. since 2018.
Formerly Legal Director at Stemcentrx, Inc. from 2012 to 2017.
Also worked as Head-Legal, Research & Development at AbbVie Stemcentrx LLC.
Education includes a doctorate from the University of Cambridge in 2004, a graduate degree from the University of Oxford in 2009, graduate and undergraduate degrees from the University of Cape Town in 2001 and 2000 respectively, and a graduate degree from BPP Law School in 2006.

Actieve functies van Galya Blachman

BedrijvenFunctieBegin
501 ACQU Algemeen Adviseur 01-09-2020
ENLIVEN THERAPEUTICS, INC. Algemeen Adviseur 01-07-2023
Algemeen Adviseur 01-06-2018
Algemeen Adviseur 01-09-2018

Eerdere bekende functies van Galya Blachman

BedrijvenFunctieEinde
Algemeen Adviseur 01-01-2017
AbbVie Stemcentrx LLC
Corporate Officer/Principal -
Ervaring van Galya Blachman in detail bekijken

Opleiding van Galya Blachman

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

89

Eerstegraads connecties

10

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit10

Health Technology

Consumer Services

Consumer Services

Consumer Services

Finance

Consumer Services

AbbVie Stemcentrx LLC

Finance

Health Technology

  1. Beurs
  2. Insiders
  3. Galya Blachman